Relationship between obesity, insulin resistance, and coronary heart disease risk

被引:398
作者
Abbasi, F
Brown, BW
Lamendola, C
McLaughlin, T
Reaven, GM
机构
[1] Stanford Univ, Sch Med, Falk CVRC, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
关键词
D O I
10.1016/S0735-1097(02)02051-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The study goals were to: 1) define the relationship between body mass index (BMI) and insulin resistance in 314 nondiabetic, normotensive, healthy volunteers; and 2) determine the relationship between each of these two variables and coronary heart disease (CHD) risk factors. BACKGROUND The importance of obesity as a risk factor for type 2 diabetes and hypertension is well-recognized, but its role as a CHD risk factor in nondiabetic, normotensive individuals is less well established. METHODS Insulin resistance was quantified by determining the steady-state plasma glucose (SSPG) concentration during the last 30 min of a 180-min infusion of octreotide, glucose, and insulin. In addition, nine CHD risk factors: age, systolic blood pressure, diastolic blood pressure (DBP), total cholesterol, triglycerides (TG), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein cholesterol concentrations, and glucose and insulin responses to a 75-g oral glucose load were measured in the volunteers. RESULTS The BMI and the SSPG concentration were significantly related (r = 0.465, p < 0.001). The BMI and SSPG were both independently associated with each of the nine risk factors. In multiple regression analysis, SSPG concentration added modest to substantial power to BMI with regard to the prediction of DBP, HDL cholesterol and TG concentrations, and the glucose and insulin responses. CONCLUSIONS Obesity and insulin resistance are both powerful predictors of CHD risk, and insulin resistance at any given degree of obesity accentuates the risk of CHD and type 2 diabetes.
引用
收藏
页码:937 / 943
页数:7
相关论文
共 34 条
[1]   Hypertriglyceridemia as a cardiovascular risk factor [J].
Austin, MA ;
Hokanson, JE ;
Edwards, KL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :7B-12B
[2]   RELATIONSHIP BETWEEN OBESITY AND MAXIMAL INSULIN-STIMULATED GLUCOSE-UPTAKE INVIVO AND INVITRO IN PIMA-INDIANS [J].
BOGARDUS, C ;
LILLIOJA, S ;
MOTT, D ;
REAVEN, GR ;
KASHIWAGI, A ;
FOLEY, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :800-805
[3]  
Depres JP, 1996, NEW ENGL J MED, V334, P952
[4]   RELATIONSHIP OF PLASMA-INSULIN LEVELS TO THE INCIDENCE OF MYOCARDIAL-INFARCTION AND CORONARY HEART-DISEASE MORTALITY IN A MIDDLE-AGED POPULATION [J].
DUCIMETIERE, P ;
ESCHWEGE, E ;
PAPOZ, L ;
RICHARD, JL ;
CLAUDE, JR ;
ROSSELIN, G .
DIABETOLOGIA, 1980, 19 (03) :205-210
[5]  
EVERHART J, 1985, DIABETES AM
[6]   Insulin resistance and hypersecretion in obesity [J].
Ferrannini, E ;
Natali, A ;
Bell, P ;
CavalloPerin, P ;
Lalic, N ;
Mingrone, G .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1166-1173
[7]   Overweight and obesity in the United States: prevalence and trends, 1960-1994 [J].
Flegal, KM ;
Carroll, MD ;
Kuczmarski, RJ ;
Johnson, CL .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (01) :39-47
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]   ASSESSMENT OF INSULIN RESISTANCE WITH THE INSULIN SUPPRESSION TEST AND THE EUGLYCEMIC CLAMP [J].
GREENFIELD, MS ;
DOBERNE, L ;
KRAEMER, F ;
TOBEY, T ;
REAVEN, G .
DIABETES, 1981, 30 (05) :387-392
[10]   INCIDENCE OF TYPE-II DIABETES IN MEXICAN-AMERICANS PREDICTED BY FASTING INSULIN AND GLUCOSE-LEVELS, OBESITY, AND BODY-FAT DISTRIBUTION [J].
HAFFNER, SM ;
STERN, MP ;
MITCHELL, BD ;
HAZUDA, HP ;
PATTERSON, JK .
DIABETES, 1990, 39 (03) :283-288